Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardiff Oncology (CRDF) Current Leases (2019 - 2025)

Historic Current Leases for Cardiff Oncology (CRDF) over the last 7 years, with Q3 2025 value amounting to $726000.0.

  • Cardiff Oncology's Current Leases rose 268.74% to $726000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $726000.0, marking a year-over-year increase of 268.74%. This contributed to the annual value of $710000.0 for FY2024, which is 274.96% up from last year.
  • According to the latest figures from Q3 2025, Cardiff Oncology's Current Leases is $726000.0, which was up 268.74% from $721000.0 recorded in Q2 2025.
  • Cardiff Oncology's Current Leases' 5-year high stood at $726000.0 during Q3 2025, with a 5-year trough of $402000.0 in Q2 2021.
  • For the 5-year period, Cardiff Oncology's Current Leases averaged around $662368.4, with its median value being $683000.0 (2023).
  • Its Current Leases has fluctuated over the past 5 years, first plummeted by 5419.36% in 2021, then soared by 6666.67% in 2022.
  • Over the past 5 years, Cardiff Oncology's Current Leases (Quarter) stood at $551000.0 in 2021, then increased by 22.5% to $675000.0 in 2022, then grew by 2.37% to $691000.0 in 2023, then increased by 2.75% to $710000.0 in 2024, then rose by 2.25% to $726000.0 in 2025.
  • Its Current Leases was $726000.0 in Q3 2025, compared to $721000.0 in Q2 2025 and $716000.0 in Q1 2025.